The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]
NYS Entity Status
NYS Filing Date
APRIL 30, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2014 - BLINDS PRODUCTIONS INC.
Around the Web
- FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
By Ben Fidler - Tuesday Aug 29, 2017
- Judge Backs Making Consumer Websites Accessible to Blind
Tuesday Jun 13, 2017
A federal judge in Florida ruled Tuesday that grocery chain Winn-Dixie Stores Inc. must make its website accessible to the blind, following an unprecedented trial over a gray area of accessibility law.
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- Economic Trends: To Understand Rising Inequality, Consider the Janitors at Two Top Companies, Then and Now
By NEIL IRWIN - Sunday Sep 3, 2017
Focusing on core competence and outsourcing the rest has made U.S. companies lean, nimble and productive. It has also left lots of people worse off.
- Disney’s ‘Magic Bench’ Fixes AR’s Biggest Blind Spot
By Brian Barrett - Tuesday Aug 8, 2017
Forget the clunky headset. All this brain-bending experience asks of you is that you take a seat.
- A Rare Conversation About Class Brings ‘The Bachelorette’ Into the Real World
By JOE COSCARELLI and CARYN GANZ - Tuesday Jul 11, 2017
One of Rachel Lindsay’s suitors tells her about the challenges he faced growing up in Baltimore, forcing the show to face its blind spot about class.